- Report
- November 2026
- 198 Pages
Global
From €5407EUR$5,850USD£4,507GBP
- Report
- November 2026
- 481 Pages
Global
From €5407EUR$5,850USD£4,507GBP
- Report
- November 2026
- 233 Pages
Global
From €5407EUR$5,850USD£4,507GBP
- Report
- July 2026
- 120 Pages
Global
From €4390EUR$4,750USD£3,660GBP
- Report
- July 2026
- 110 Pages
Global
From €4390EUR$4,750USD£3,660GBP
- Report
- September 2026
- 140 Pages
Global
From €4390EUR$4,750USD£3,660GBP
- Report
- July 2026
- 135 Pages
Global
From €4390EUR$4,750USD£3,660GBP
- Report
- February 2026
- 218 Pages
Global
From €4617EUR$4,995USD£3,849GBP
- Report
- August 2026
- 160 Pages
Global
From €3069EUR$3,320USD£2,558GBP
€3836EUR$4,150USD£3,198GBP
- Report
- August 2026
- 160 Pages
Global
From €3069EUR$3,320USD£2,558GBP
€3836EUR$4,150USD£3,198GBP
- Report
- November 2025
- 160 Pages
Global
From €2921EUR$3,160USD£2,435GBP
€3651EUR$3,950USD£3,043GBP
- Report
- July 2026
- 342 Pages
Global
From €3500EUR$4,056USD£3,020GBP
- Report
- April 2026
- 113 Pages
Global
From €3500EUR$4,056USD£3,020GBP
- Report
- April 2026
- 106 Pages
Global
From €3500EUR$4,056USD£3,020GBP
- Report
- July 2026
- 152 Pages
Global
From €3500EUR$4,056USD£3,020GBP
- Report
- January 2026
- 160 Pages
Global
From €4483EUR$4,850USD£3,737GBP
- Newsletter
- November 2026
- 75 Pages
Global
€4390EUR$4,750USD£3,660GBP
- Report
- April 2026
- 52 Pages
Global
From €6932EUR$7,500USD£5,779GBP
- Report
- March 2026
- 226 Pages
Global
From €4617EUR$4,995USD£3,849GBP
- Report
- March 2026
- 73 Pages
Global
From €4617EUR$4,995USD£3,849GBP

The Demineralized Bone Matrix (DBM) market is a subset of the larger biomaterials industry. DBM is a type of bone graft material that is used to repair and regenerate bone tissue. It is composed of collagen and other proteins, and is processed to remove the mineral content. DBM is used in a variety of orthopedic and dental procedures, including spinal fusion, fracture repair, and dental implantation. It is also used in reconstructive surgery, such as facial reconstruction.
DBM is a growing market, with increasing demand for its use in a variety of medical procedures. It is a cost-effective alternative to autografts, and is gaining popularity due to its biocompatibility and ability to promote bone regeneration.
Some companies in the DBM market include Zimmer Biomet, Medtronic, Stryker, and Orthofix. Show Less Read more